Cargando…

Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience

BACKGROUND: With juvenile idiopathic arthritis (JIA), there are several protocols and practices used worldwide for the transition from paediatric to adult care. In this study, we examined the transferral rates and disease activity after transition, as well as the disease- and health-related outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mikola, Katriina, Rebane, Katariina, Arnstad, Ellen Dalen, Berntson, Lillemor, Fasth, Anders, Glerup, Mia, Herlin, Troels, Kautiainen, Hannu, Nielsen, Susan, Nordal, Ellen, Peltoniemi, Suvi, Rygg, Marite, Rypdal, Veronika, Zak, Marek, Aalto, Kristiina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526898/ https://www.ncbi.nlm.nih.gov/pubmed/36182898 http://dx.doi.org/10.1186/s12969-022-00742-2

Ejemplares similares

Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study
por: Rypdal, Veronika, et al.
Publicado: (2018)

Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort
por: Arnstad, Ellen Dalen, et al.
Publicado: (2021)

Participation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study
por: Nordal, Ellen, et al.
Publicado: (2019)

Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort
por: Glerup, Mia, et al.
Publicado: (2019)

Prognostic factors for the disease course and 8-year outcome in Nordic children with oligoarticular-onset juvenile idiopathic arthritis
por: Peltoniemi, Suvi, et al.
Publicado: (2014)

Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study
por: Nordal, Ellen, et al.
Publicado: (2017)

Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1—results of the Canadian model in the Nordic cohort
por: Rypdal, Veronika, et al.
Publicado: (2019)

Ongoing disease-activity and change in ILAR categories in a Nordic juvenile idiopathic arthritis cohort
por: Nordal, Ellen, et al.
Publicado: (2012)

Histone antibodies as a biomarker of uveitis in JIA
por: Nordal, Ellen B, et al.
Publicado: (2014)

Juvenile arthritis disease activity score (JADAS) based on C-reactive protein predicts DMARD treatment in juvenile idiopathic arthritis in a Nordic multicenter cohort
por: Nordal, Ellen, et al.
Publicado: (2012)

Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up study
por: Ekelund, Maria, et al.
Publicado: (2017)

Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA)
por: Berntson, Lillemor, et al.
Publicado: (2014)

PReS-FINAL-2046: Uveitis in the Nordic juvenile idiopathic arthritis cohort; high incidence, frequent complications, and gender-associated risk factors
por: Nordal, EB, et al.
Publicado: (2013)

Ankle arthritis predicts worse outcome in children with juvenile idiopathic arthritis
por: Esbjörnsson, Anna-Clara, et al.
Publicado: (2014)

Juvenile Arthritis Disease Activity Score (JADAS) based on CRP; validity and predictive ability in a Nordic population-based setting
por: Nordal, EB, et al.
Publicado: (2011)

M-ficolin: a valuable biomarker to identify leukaemia from juvenile idiopathic arthritis
por: Brix, Ninna, et al.
Publicado: (2022)

Non-HLA genepolymorphisms in juvenile chronic arthritis: associations with outcome of disease
por: Alberdi-Saugstrup, Mikel, et al.
Publicado: (2014)

PReS-FINAL-2071: Anti-type II collagen antibodies, anti-CCP, IgA-RF and IgM-RF are associated with joint damage eight years after onset of juvenile idiopathic arthritis (JIA)
por: Berntson, L, et al.
Publicado: (2013)

Pain sensitivity in young adults with juvenile idiopathic arthritis: a quantitative sensory testing study
por: Arnstad, Ellen Dalen, et al.
Publicado: (2020)

HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis
por: Berntson, L, et al.
Publicado: (2008)

A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
por: Foell, Dirk, et al.
Publicado: (2023)

Neurophysiologic pain response in patients with juvenlie idiopathic arthritis - a pilot study
por: Iversen, Johanne Marie M, et al.
Publicado: (2014)

Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort
por: Henrey, Andrew, et al.
Publicado: (2020)

Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study
por: Peltoniemi, Suvi Oili Orvokki, et al.
Publicado: (2023)

May antihistone antibodies replace antinuclear antibodies (ANA) as a predictor of uveitis in Juvenile idiopathic arthritis?
por: Nordal, EB, et al.
Publicado: (2008)

Oral health-related quality of life, impaired physical health and orofacial pain in children and adolescents with juvenile idiopathic arthritis – a prospective multicenter cohort study
por: Halbig, Josefine M., et al.
Publicado: (2023)

Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study
por: Levälampi, Tiina, et al.
Publicado: (2023)

The Norwegian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Flato, Berit, et al.
Publicado: (2018)

A pilot study of possible anti-inflammatory effects of the specific carbohydrate diet in children with juvenile idiopathic arthritis
por: Berntson, Lillemor
Publicado: (2021)

Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis
por: Tarkiainen, Maarit, et al.
Publicado: (2022)

Severe Raynaud’s phenomenon from ethosuximide raised concern over possible onset of systemic vasculitis: a case report
por: Berntson, Lillemor, et al.
Publicado: (2022)

Cardiac Differentiation of Pluripotent Stem Cells
por: Rajala, Kristiina, et al.
Publicado: (2011)

The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Lahdenne, Pekka, et al.
Publicado: (2018)

A cross-sectional cohort study of the activity and turnover of neutrophil granulocytes in juvenile idiopathic arthritis
por: Backlund, Malin, et al.
Publicado: (2021)

A Comparative View on Easy to Deploy non-Integrating Methods for Patient-Specific iPSC Production
por: Manzini, Stefano, et al.
Publicado: (2015)

Preterm birth and asthma and COPD in adulthood: a nationwide register study from two Nordic countries
por: Pulakka, Anna, et al.
Publicado: (2023)

A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities
por: Beukelman, Timothy, et al.
Publicado: (2017)

Environmental Sustainability Perspectives of the Nordic Diet
por: Meltzer, Helle Margrete, et al.
Publicado: (2019)

Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
por: Öman, Anders, et al.
Publicado: (2021)

A Pilot Study Investigating Faecal Microbiota After Two Dietary Interventions in Children with Juvenile Idiopathic Arthritis
por: Berntson, Lillemor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n9knv32dvr5jecodk1918b9121